Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 616–630 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2623 RIN2 Gene Macrocephaly, Alopecia, Cutis Laxa, & Scoliosis Genetic Test This genetic test evaluates the entire coding region of the RIN2 gene for pathogenic variants associated with MACS syndrome.	Whole Blood (EDTA) or DNA FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RIN2 gene", "Full coding region analysis"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session mandatory", "Clinical history form completion required before phlebotomy"] Indications ["Clinical suspicion of MACS syndrome", "Need for definitive molecular diagnosis", "Family counseling and surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 95278-0 ICD-10: Q87.8 Clinical summary This genetic test evaluates the entire coding region of the RIN2 gene for pathogenic variants associated with MACS syndrome.
TEST-2423 RIPK4 Gene (Popliteal Pterygium Syndrome, Lethal Type) Genetic Test This test identifies pathogenic variants in the RIPK4 gene associated with lethal popliteal pterygium syndrome.	Whole Blood (EDTA), FTA Card, or Buccal Swab (Extracted DNA accepted)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation [] Indications ["Suspected lethal popliteal pterygium syndrome", "Family history of popliteal pterygium syndrome", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 48767-8 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the RIPK4 gene associated with lethal popliteal pterygium syndrome.
TEST-3908 RNF128 Gene Autism Genetic Test This test sequences the RNF128 gene to detect pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) with Sanger confirmation...	Peripheral whole blood (EDTA tube) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the RNF128 gene", "Coding exons and canonical splice sites of the RNF128 gene"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "No specific fasting or medication adjustments required for the blood sample"] Indications ["Diagnosis of Autism Spectrum Disorder (ASD)", "Family risk assessment for ASD", "Genetic counselling for individuals with ASD"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: F84.0, Z13.858, Z15.89 Clinical summary This test sequences the RNF128 gene to detect pathogenic variants associated with Autism Spectrum Disorder (ASD). It uses Next-Generation Sequencing (NGS) with Sanger confirmation for high diagnostic sensitivity.
TEST-4028 RNF213 Gene Susceptibility for Moyamoya Disease Type 2 (Genetic Testing) Test This genetic test evaluates the RNF213 gene for pathogenic variants associated with Moyamoya disease type 2.	Whole Blood (EDTA) or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RNF213 gene"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of bleeding disorders or anticoagulant use"] Indications ["Family history of Moyamoya disease", "Clinical suspicion of Moyamoya disease", "Risk assessment for Moyamoya disease"] Measurement technique Confirm with laboratory Codes LOINC: 74832-3 ICD-10: I67.5 Clinical summary This genetic test evaluates the RNF213 gene for pathogenic variants associated with Moyamoya disease type 2.
TEST-4504 ROBO3 Gene Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS) Genetic Test This genetic test identifies pathogenic variants in the ROBO3 gene associated with Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ROBO3 gene", "Coverage of ROBO3 coding regions and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected diagnosis of Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS)", "Individuals with clinical features suggestive of HGPPS"] Measurement technique Confirm with laboratory Codes LOINC: 96993-9 ICD-10: H51.8 Clinical summary This genetic test identifies pathogenic variants in the ROBO3 gene associated with Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS).
TEST-4073 RPGRIP1L Gene COACH Syndrome Genetic Test This test provides definitive molecular confirmation of COACH syndrome by identifying pathogenic variants in the RPGRIP1L gene.	Whole blood or dried blood spot (peripheral)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RPGRIP1L gene pathogenic variants"] Parameters [] Preparation ["No fasting required.", "Do not discontinue prescribed medication without consulting your physician.", "Mandatory pre-test genetic counseling is required.", "A signed informed consent document must be completed during counseling."] Indications ["Suspected COACH syndrome", "Genetic counseling", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81403-8 ICD-10: Q04.3 Clinical summary This test provides definitive molecular confirmation of COACH syndrome by identifying pathogenic variants in the RPGRIP1L gene.
TEST-3290 RPL15 Gene Diamond-Blackfan Anemia Type 12 Genetic Test This test identifies pathogenic variants in the RPL15 gene associated with Diamond-Blackfan anemia type 12.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks (Express available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPL15 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected Diamond-Blackfan anemia", "Family history of Diamond-Blackfan anemia", "Pre-transplant evaluation", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 48000-4 ICD-10: D61.0 Clinical summary This test identifies pathogenic variants in the RPL15 gene associated with Diamond-Blackfan anemia type 12.
TEST-3297 RPS26 Gene Diamond-Blackfan Anemia Type 10 Genetic Test (NGS) This test analyzes the RPS26 gene for mutations associated with Diamond-Blackfan Anemia Type 10.	Peripheral blood (whole blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RPS26 gene sequence", "Single nucleotide variants", "Indels", "Large deletions"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Provide detailed family history", "Attend pre-test genetic counseling session"] Indications ["Suspected Diamond-Blackfan Anemia Type 10", "Family history of Diamond-Blackfan Anemia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: D61.01 Clinical summary This test analyzes the RPS26 gene for mutations associated with Diamond-Blackfan Anemia Type 10.
TEST-5585 RSPH4A Gene Primary Ciliary Dyskinesia Type 11 Genetic Test This genetic test identifies mutations in the RSPH4A gene associated with primary ciliary dyskinesia type 11.	Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RSPH4A gene mutations", "Copy Number Variations (CNVs) in the RSPH4A gene"] Parameters [] Preparation ["Pre-test genetic counseling is recommended"] Indications ["Suspected primary ciliary dyskinesia type 11", "Family history of PCD", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81269-5 ICD-10: Q34.8 Clinical summary This genetic test identifies mutations in the RSPH4A gene associated with primary ciliary dyskinesia type 11.
TEST-4614 RYR1 Gene Sequencing for King-Denborough Syndrome Test This test evaluates the RYR1 gene for pathogenic variants associated with King-Denborough syndrome and malignant hyperthermia susceptibility.	Peripheral whole blood (preferred) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RYR1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting a doctor"] Indications ["Suspected King-Denborough syndrome", "Evaluation of malignant hyperthermia susceptibility", "Family screening for RYR1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82283-4 ICD-10: G71.2 Clinical summary This test evaluates the RYR1 gene for pathogenic variants associated with King-Denborough syndrome and malignant hyperthermia susceptibility.
TEST-3628 SALL4 Gene Analysis for Duane Retraction Syndrome (Genetic Test) This test identifies pathogenic variants in the SALL4 gene associated with Duane retraction syndrome and related disorders.	Peripheral Whole Blood (EDTA tube) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SALL4 gene sequence variants (SNVs, Indels)", "SALL4 gene copy number variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Inform the team of any bleeding disorders or anticoagulant medication", "A mandatory pre-test genetic counselling session is required"] Indications ["Suspected Duane retraction syndrome (DRS)", "Suspected Okihiro syndrome (Duane-radial ray syndrome)", "Family history of DRS or related disorders", "Need for genetic counselling and reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21705-3 ICD-10: Z13.71, H50.813, Q87.0 Clinical summary This test identifies pathogenic variants in the SALL4 gene associated with Duane retraction syndrome and related disorders.
TEST-3634 SAMD9 Gene Mirage Syndrome Genetic Test This test analyzes the SAMD9 gene for pathogenic variants associated with Mirage syndrome using Next-Generation Sequencing.	Peripheral Blood (FTA card or venous draw)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in SAMD9 gene", "Small indels in SAMD9 gene", "Copy number variations (CNV) in SAMD9 gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion ( Indications ["Suspected clinical diagnosis of Mirage syndrome", "Differentiation from other bone marrow failure syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 93390-1 ICD-10: Q87.89, D46.9, Z15.89 Clinical summary This test analyzes the SAMD9 gene for pathogenic variants associated with Mirage syndrome using Next-Generation Sequencing.
TEST-3747 SAMHD1 Gene Aicardi-Goutières Syndrome Type 5 Genetic Test This genetic test detects pathogenic variants in the SAMHD1 gene to diagnose Aicardi-Goutières syndrome type 5.	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SAMHD1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Aicardi-Goutières syndrome type 5", "Early-onset encephalopathy of unknown origin", "Family history of Aicardi-Goutières syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 92841-1 ICD-10: G31.82, Z13.71 Clinical summary This genetic test detects pathogenic variants in the SAMHD1 gene to diagnose Aicardi-Goutières syndrome type 5.
TEST-6000 SBDS Gene-Related Aplastic Anemia Genetic Test This test evaluates the SBDS gene for pathogenic variants associated with Shwachman-Diamond syndrome and constitutional aplastic anemia.	Peripheral blood, extracted DNA, or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SBDS gene coding region", "Copy Number Variations (CNV)"] Parameters [] Preparation ["Do not discontinue prescribed medication or supplements affecting blood counts without physician instruction."] Indications ["Suspected Shwachman-Diamond syndrome", "Constitutional aplastic anemia", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D61.0 Clinical summary This test evaluates the SBDS gene for pathogenic variants associated with Shwachman-Diamond syndrome and constitutional aplastic anemia.
TEST-4437 SCN1A Gene Sequencing for GEFS+ Type 2 Test This test identifies pathogenic variants in the SCN1A gene associated with Generalized Epilepsy with Febrile Seizures Plus (GEFS+) Type 2.	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SCN1A gene", "Sodium channel dysfunction"] Parameters [] Preparation [] Indications ["Diagnosis of GEFS+ Type 2", "Guiding antiepileptic therapy", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48306-0 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the SCN1A gene associated with Generalized Epilepsy with Febrile Seizures Plus (GEFS+) Type 2.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.